3Hanifin JM,Reed ML.Eczema prevalence and impact working group.A population-based survey of eczema prevalence in the United States.Dermatitis,2007,18(2):82-91.
2Weismann K, Hjorth N. Microbial eczema of the feet [J]. BrJ Dermatol, 1982, 107(3):333-337.
3Shrank AB. Infective eczema[ J]. Br Med J, 1967, 1 (5536) : 349 -351.
4Wehner J, Neuber K. Staphy tococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema[J]. Br J Dermatol, 2001, 145(2) : 302 -305.
5Boque M, Carballada F. Childhood asthma and viral infection : interactions and therapeutic possibilities [ J ]. Al- lergol Immuopathol, 2001,29(3) : 133 - 140.
6Korossy S. Microbial eczema. Staphylococcal and streptococcal hypersensitivity. In: Rajka E and Korossy S(ed) [ J ]. Immunological aspects of allergy and allergic diseases 7, Allergic diseases of the skin Plenum Press, New York, 1976:232-376.
7Sakurane M, Shinotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori - positive Japanese patients [ J]. J Dermatol, 2002, 29 ( 1 ) : 23 - 27.
8Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol, 1998, 139Suppl 53:13-16.
9Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Center,Singapore. Int J Dermatol, 1997, 36: 653-657.
10Breuer K, Haussler S, Kapp A, et al. Staphylococcus aureus: colonizaing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol, 2002, 147: 55-61.
